Society Of Urologic Oncology Clinical Trials Consortium — 2020 IRS Filing

EIN: 262943602 · Tax Year 2020 · Source: IRS Form 990

$214KTotal Revenue
$163KTotal Expenses
$497KNet Assets

Financial Summary

MetricAmount
Total Revenue$214K
Total Expenses$163K
Net Income$51K
Total Assets (End of Year)$497K

Frequently Asked Questions

What was Society Of Urologic Oncology Clinical Trials Consortium's revenue in 2020?

Society Of Urologic Oncology Clinical Trials Consortium reported $214K in total revenue for the 2020 tax year, with $163K in total expenses and $497K in net assets.

How did Society Of Urologic Oncology Clinical Trials Consortium spend its money in 2020?

Detailed spending breakdown data is not available for Society Of Urologic Oncology Clinical Trials Consortium's 2020 filing.

Where does this 2020 filing data come from?

This data comes from Society Of Urologic Oncology Clinical Trials Consortium's IRS Form 990 filed for the 2020 tax year. Form 990 is a public document that all tax-exempt organizations must file annually with the IRS.

Understanding IRS Form 990

The IRS Form 990 is a public document that tax-exempt organizations must file annually. It provides detailed information about an organization's finances, governance, and activities. Key sections include revenue and expenses, compensation of officers, and program accomplishments.

All data shown on this page comes directly from Society Of Urologic Oncology Clinical Trials Consortium's publicly available IRS Form 990 for the 2020 tax year. This information is provided for transparency and research purposes.

Other Filing Years

2023 2022 2021 2019 2018 2017 2016 2015 2014 2013 2012

Related Pages